[ET Net News Agency, 24 April 2025] HANSOH PHARMA (03692) rose 3.2% to HK$24.5.
It hits an intra-day high of HK$24.5, and an intra-day low of HK$23.7. The total shares
traded was 1.23 million, with a value of HK$29.5m. The active buy/sell ratio is 70:30,
with net buying turnover of HK$10.58m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net
responsive buying turnover of HK$1.54m, with volume weighted average price of HK$24.081.
CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of
HK$3.22m, with volume weighted average price of HK$24.183. The stock has risen a combined
12.1% over the past 4 consecutive trading days.
The Hang Seng Index now rose 1 point, or less than 0.1% to 22,074.

Basic Information
=================

---------------------------------
Nominal 24.500 % Chg +3.16%
High 24.500 Low 23.700
Shares Tr 1.23m Turnover 29.5m
10-D SMA 22.710 %H.V 69.285
20-D SMA 22.705 VWAP 24.066
50-D SMA 20.404 RSI14 65.668
---------------------------------
Status: Active buy/sell ratio is 70:30, with net buying turnover of HK$10.58m, rising a
combined 12.1% over the past 4 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 24.50 +3.16
SIHUAN PHARM (00460) 0.65 Unchanged
GRAND PHARMA (00512) 6.02 +0.33
SINO BIOPHARM (01177) 3.91 +1.82
LIVZON PHARMA (01513) 27.00 +0.75
LUYE PHARMA (02186) 2.03 +1.50
FOSUN PHARMA (02196) 14.96 +2.19
SH PHARMA (02607) 10.82 -0.18
JACOBSON PHARMA (02633) 1.21 -0.82
CHINARES PHARMA (03320) 4.98 +0.20
-----------------------------------------------
(ed)